Reduced Versus Conventional Dose Insulin for Hyperkalemia Treatment

Area of Science:

• Internal Medicine
• Nephrology
• Endocrinology

Background:

• Reduced insulin doses (5 units) are proposed to lower hypoglycemia risk during hyperkalemia treatment.
• Comparative data on reduced vs. conventional (10 units) insulin efficacy and safety is limited.

Purpose of the Study:

• To compare the effectiveness of reduced-dose versus conventional-dose insulin in treating hyperkalemia.
• To evaluate the impact of insulin dosing on serum potassium levels.

Main Methods:

• Retrospective review of electronic medication administration records (July 2013 - September 2015).
• Included patients receiving conventional or reduced insulin doses for hyperkalemia.
• Primary outcome: reduction in serum potassium concentration.

Main Results:

• No significant difference in potassium reduction between reduced (92) and conventional (309) insulin doses (P = .2210).
• Subgroup analysis (serum potassium > 6 mmol/L) showed greater potassium reduction with conventional insulin (difference: -0.238 mmol/L, P = .018).

Conclusions:

• Conventional insulin doses may be more effective for hyperkalemia when baseline serum potassium exceeds 6 mmol/L.
• Close monitoring of serum potassium and glucose is essential post-insulin administration to ensure efficacy and prevent hypoglycemia.